Patricia Carr, VP, Finance & PAO at Jazz Pharmaceuticals plc (JAZZ), sold 142 shares at $123.80 ($18K) on 2020-08-12, disclosed to the SEC on 2020-08-14.
Scheduled sale ($18k) by VP, Finance & PAO under a pre-arranged 10b5-1 plan. Pre-set trade — not a discretionary signal on the stock.
Nothing distinguishes this filing.
| Filing → |
| JAZZ | SELL | 2025-12-09 | $798K | — | Filing → |
| JAZZ | SELL | 2025-11-20 | $1.9M | — | Filing → |
| JAZZ | SELL | 2025-03-11 | $314K | — | Filing → |